Clinical Trial Update: Scleroderma: Cyclophosphamide or Transplantation [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update comparing cyclophosphamide versus transplantation in systemic sclerosis (scleroderma) completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scleroderma
• Systemic Sclerosis

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Scleroderma, Systemic, Sclerosis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-07-14